HEPATOLOGY

Scope & Guideline

Transforming liver health with groundbreaking insights.

Introduction

Welcome to the HEPATOLOGY information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of HEPATOLOGY, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN0270-9139
PublisherLIPPINCOTT WILLIAMS & WILKINS
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1981 to 2024
AbbreviationHEPATOLOGY / Hepatology
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103

Aims and Scopes

The journal 'Hepatology' focuses on advancing the understanding, prevention, diagnosis, and treatment of liver diseases through rigorous research and clinical studies. Its scope encompasses a broad range of topics related to hepatology, including but not limited to viral hepatitis, liver cancer, fatty liver disease, and liver transplantation. The journal aims to disseminate high-quality research findings that can influence clinical practice and improve patient outcomes.
  1. Viral Hepatitis Research:
    This area includes studies on the epidemiology, pathogenesis, and treatment of hepatitis viruses (A, B, C, D, and E), focusing on novel antiviral therapies and their clinical implications.
  2. Liver Cancer and Oncology:
    Research on hepatocellular carcinoma (HCC) and cholangiocarcinoma, including mechanisms of tumorigenesis, therapeutic strategies, and outcomes of various treatment modalities.
  3. Liver Disease Mechanisms:
    Investigations into the cellular and molecular mechanisms underlying liver diseases such as non-alcoholic fatty liver disease (NAFLD), alcohol-related liver disease, and autoimmune liver conditions.
  4. Transplantation and Regenerative Medicine:
    Studies focused on liver transplantation, including donor selection, post-transplant outcomes, and the role of stem cells and organoids in liver regeneration.
  5. Clinical Guidelines and Practice:
    The journal publishes consensus guidelines and practice recommendations to improve the management of liver diseases, emphasizing evidence-based approaches.
  6. Innovative Diagnostic Techniques:
    Research utilizing advanced diagnostic modalities such as imaging techniques, serum biomarkers, and non-invasive fibrosis assessment methods for better disease characterization.
  7. Public Health and Epidemiology:
    Articles addressing the epidemiological aspects of liver diseases, including the impact of lifestyle factors, health disparities, and public health initiatives for prevention and management.
Recent publications in 'Hepatology' indicate several trending and emerging themes that reflect the evolving landscape of liver disease research. These themes highlight innovative approaches, novel therapeutic strategies, and a comprehensive understanding of liver disease mechanisms.
  1. Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD):
    Research on MAFLD is gaining momentum, emphasizing the need for updated diagnostic criteria and treatment strategies that address the metabolic aspects of liver disease.
  2. Artificial Intelligence in Hepatology:
    The integration of AI and machine learning techniques for diagnosing liver diseases, predicting outcomes, and personalizing treatment regimens is becoming increasingly prominent.
  3. Personalized Medicine Approaches:
    Emerging studies focusing on tailoring therapies based on individual patient characteristics, genetic profiles, and specific disease phenotypes are trending.
  4. Non-Invasive Diagnostic Modalities:
    There is a marked increase in research on non-invasive techniques for diagnosing liver conditions, including transient elastography, MRI-based assessments, and blood-based biomarkers.
  5. Gut-Liver Axis Research:
    The exploration of the gut microbiome's role in liver disease pathogenesis and treatment responses is an emerging area of interest, linking gastrointestinal health to liver outcomes.
  6. Longitudinal Studies and Real-World Evidence:
    There is a growing trend towards longitudinal studies that provide real-world evidence on the effectiveness of therapies and the natural history of liver diseases.
  7. Public Health Interventions:
    Research focusing on the impact of public health policies and community-based interventions for liver disease prevention and management is gaining traction.

Declining or Waning

While 'Hepatology' has consistently covered various aspects of liver diseases, certain research areas appear to be declining in prominence based on recent publications. This may reflect shifting priorities within the field, advancements in understanding, or the saturation of existing knowledge in those areas.
  1. Traditional Liver Biopsy Techniques:
    There has been a noticeable decline in studies focused on traditional liver biopsy methods as non-invasive techniques for assessing liver fibrosis gain popularity and acceptance.
  2. Alcohol-Induced Liver Disease:
    Although still an important topic, research specifically focused on classic alcohol-induced liver disease may be waning as attention shifts towards broader metabolic dysfunction-associated liver diseases (MASH) and their multifactorial causes.
  3. Basic Science Studies:
    The journal has seen fewer purely basic science studies as there is a growing emphasis on translational research that can directly impact clinical practice and patient care.
  4. Viral Hepatitis Monotherapy Studies:
    Research focusing solely on monotherapy for hepatitis treatments is declining in favor of combination therapies that target multiple pathways and improve treatment efficacy.
  5. Outdated Diagnostic Biomarkers:
    Research on older biomarkers for liver disease diagnosis is decreasing as newer, more effective biomarkers are developed and validated.

Similar Journals

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Advancing the Frontiers of Gastrointestinal and Liver Research
Publisher: AMER PHYSIOLOGICAL SOCISSN: 0193-1857Frequency: 12 issues/year

American Journal of Physiology-Gastrointestinal and Liver Physiology, published by the American Physiological Society, stands as a leading journal in the domains of gastroenterology, hepatology, and overall physiology. With an impressive impact factor and consistent ranking in the Q1 quartile across multiple categories, this journal provides a vital platform for disseminating advanced research and innovative findings related to gastrointestinal and liver physiology. Since its inception in 1980, the journal has fostered a community of researchers and clinicians dedicated to understanding and improving digestive and liver health. While maintaining a traditional subscription model, it ensures high-quality peer-reviewed content that is crucial for informed professional practice and academic inquiry. The journal’s Scopus ranks highlight its significant impact in the fields of gastroenterology and hepatology, making it an indispensable resource for academics and practitioners alike, eagerly exploring both foundational and cutting-edge topics in physiology.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Elevating standards in gastrointestinal and liver disease research.
Publisher: WILEYISSN: 0815-9319Frequency: 12 issues/year

Welcome to the JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, an esteemed publication in the field of gastroenterology and hepatology, proudly published by WILEY. Established in 1986, this journal serves as a crucial platform for researchers, healthcare professionals, and students, presenting groundbreaking research and comprehensive reviews that drive advances in understanding and treating gastrointestinal and liver diseases. With a strong reputation evidenced by its Q1 ranking in gastroenterology and Q2 ranking in hepatology, this journal ranks impressively in the Scopus metrics - positioned at #22 out of 167 in gastroenterology and #21 out of 82 in hepatology, reflecting its contribution to scholarly excellence. Although it does not offer open access options, the journal’s rich archive and diverse topics make it indispensable for those dedicated to improving patient outcomes in these critical areas of medicine. Whether you are a seasoned researcher or an aspiring medical professional, engaging with this journal will keep you at the forefront of the latest developments and emerging trends in gastroenterology and hepatology research.

Journal of Clinical and Experimental Hepatology

Connecting experts to elevate the field of hepatology.
Publisher: ELSEVIER - DIVISION REED ELSEVIER INDIA PVT LTDISSN: 0973-6883Frequency: 4 issues/year

The Journal of Clinical and Experimental Hepatology, published by Elsevier - Division Reed Elsevier India Pvt Ltd, is a premier platform dedicated to advancing the field of hepatology. With an ISSN of 0973-6883 and an E-ISSN of 2213-3453, this journal has gained recognition for its impactful contributions to both clinical practice and scientific research in the domain of liver health. Ranking in the Q2 quartile for Hepatology in 2023 and positioned at 33rd out of 82 in Scopus’s Hepatology category, it reflects a robust impact factor and a commitment to publishing high-quality, peer-reviewed articles. Researchers, clinicians, and students can engage with a wealth of open-access content covering the latest advancements, challenges, and insights in hepatology, as the journal aims to disseminate knowledge from 2011 through 2025. Join the community of experts as we explore critical developments in the understanding and treatment of liver diseases.

International Journal of Hepatology

Connecting researchers and clinicians for better liver health.
Publisher: HINDAWI LTDISSN: 2090-3448Frequency: 1 issue/year

The International Journal of Hepatology, published by HINDAWI LTD, is a premier open-access journal dedicated to the field of hepatology. Since its inception, this journal has championed the dissemination of cutting-edge research and reviews pertaining to liver health, diseases, and therapies. With an ISSN of 2090-3448, the journal has been committed to open-access publishing since 2011, ensuring that vital knowledge is readily available to researchers, clinicians, and students worldwide. Based in Egypt, this journal stands out in its category, achieving a Q3 ranking in 2023 within the scope of Hepatology by Scopus, which ranks it #43 out of 82 in the field. The International Journal of Hepatology offers a platform for significant findings and discussions that influence clinical practices and foster new research directions, thus playing a crucial role in advancing the understanding of liver diseases and their management.

Egyptian Liver Journal

Advancing hepatology through open access insights.
Publisher: SPRINGEROPENISSN: 2090-6218Frequency: 1 issue/year

The Egyptian Liver Journal, ISSN 2090-6218, is a vital resource for the hepatology community, published by SPRINGEROPEN. Since its establishment in 2012, this journal has served as a platform for disseminating significant findings in liver research, with an emphasis on enhancing understanding and treatment of liver diseases. Recognized with a Q3 ranking in Hepatology for 2023, the Egyptian Liver Journal aims to bridge the gap between research and clinical practice through its commitment to open access, fostering a global exchange of knowledge without barriers since 2019. With a focus on innovative studies, reviews, and clinical guidelines, the journal appeals to a diverse audience of researchers, clinicians, and students dedicated to advancing liver health. Situated in the heart of the United States, this publication addresses the pressing issues within the field and encourages submissions that address the future of liver care and treatment.

DIGESTIVE AND LIVER DISEASE

Bridging research and practice in gastroenterology.
Publisher: ELSEVIER SCIENCE INCISSN: 1590-8658Frequency: 12 issues/year

DIGESTIVE AND LIVER DISEASE is a prominent journal published by Elsevier Science Inc, dedicated to advancing the field of gastroenterology and hepatology. With an ISSN of 1590-8658 and an E-ISSN of 1878-3562, this journal has established itself as a significant resource within the academic community, especially considering its Q2 ranking in both gastroenterology and hepatology categories as of 2023. Spanning from 2000 to 2024, the journal presents a diverse array of peer-reviewed articles, clinical studies, and review papers that explore the latest advancements and research findings in digestive and liver diseases. The journal's robust impact, reflected in its Scopus rankings—40th out of 167 in gastroenterology and 28th out of 82 in hepatology—highlights its critical role in shaping practices and understanding in these vital areas of medicine. With open access options available, DIGESTIVE AND LIVER DISEASE aims to make high-quality research accessible to a wider audience, thereby encouraging collaboration and innovation. Researchers, healthcare professionals, and students alike will find valuable insights into the complex mechanisms, diagnostics, and therapeutic strategies pertinent to digestive and liver health.

World Journal of Hepatology

Connecting global researchers to advance hepatology knowledge.
Publisher: BAISHIDENG PUBLISHING GROUP INCISSN: 1948-5182Frequency: 12 issues/year

World Journal of Hepatology is a premier academic journal dedicated to advancing the field of hepatology. Published by BAISHIDENG PUBLISHING GROUP INC, this journal serves as a crucial platform for disseminating innovative research findings and critical reviews from around the globe. With its ISSN 1948-5182 and E-ISSN 1948-5182, the journal has established a notable presence since its inception in 2009, covering a wide range of topics relevant to liver diseases, including but not limited to hepatitis, liver cancer, and metabolic liver disorders. Currently ranked 41/82 in the field of hepatology by Scopus, representing the 50th percentile, it has achieved a Q3 quartile ranking in the 2023 category, underscoring its growing influence in the medical community. With a commitment to open access for its readership, the World Journal of Hepatology enriches the global discourse on liver health and disease management, making it an essential resource for researchers, clinicians, and students alike.

Annals of Hepatology

Elevating knowledge and collaboration in liver research.
Publisher: ELSEVIER ESPANAISSN: 1665-2681Frequency: 6 issues/year

Annals of Hepatology is an esteemed open-access journal dedicated to the dynamic field of liver research and hepatology. Published by Elsevier España since 2002, this journal has established itself as a pivotal resource for researchers and clinicians alike, boasting a remarkable impact in the medical community with its 2023 rankings placing it in the Q2 quartile for Hepatology and Q1 quartile in Medicine (Miscellaneous). With an impressive Scopus rank of #20 out of 82 in the field of Hepatology and a notable 76th percentile standing, the journal is committed to disseminating high-quality, peer-reviewed articles that advance the understanding of liver diseases and their management. The editorial scope encompasses a broad range of topics, including liver pathology, therapeutic interventions, and public health implications related to hepatic disorders. Researchers, healthcare professionals, and students interested in the latest advancements in hepatology will find Annals of Hepatology an invaluable platform for sharing and accessing knowledge, with the convenience of open access enhancing global visibility and collaboration in this critical field of medicine.

BMJ Open Gastroenterology

Empowering Global Insights in Gastrointestinal Medicine
Publisher: BMJ PUBLISHING GROUPISSN: 2054-4774Frequency: 1 issue/year

BMJ Open Gastroenterology is a premier open access journal published by the esteemed BMJ Publishing Group, focusing on the dynamic and evolving field of gastroenterology. Established in 2014, the journal has rapidly ascended in stature, reflected in its impressive 2023 Q1 ranking in gastroenterology and its position within the top 25% of journals in the category according to Scopus. With a mission to disseminate high-quality, peer-reviewed research with global significance, the journal provides a vital platform for researchers, professionals, and students alike to share their findings and advancements in gastrointestinal medicine. Operating from its headquarters in London, England, the journal's open access format ensures wide visibility and accessibility of cutting-edge research, making it an invaluable resource for those dedicated to improving patient care and driving innovation in gastroenterological sciences. By engaging with this journal, contributors and readers can stay at the forefront of critical developments in the field, fostering a collaborative environment for knowledge exchange.

Canadian Journal of Gastroenterology and Hepatology

Empowering Healthcare through Open Access Research
Publisher: HINDAWI LTDISSN: 2291-2789Frequency: 1 issue/year

Canadian Journal of Gastroenterology and Hepatology, published by HINDAWI LTD, serves as a vital resource in the fields of gastroenterology and hepatology. Since its inception in 1987, this open-access journal has made significant contributions to advancing research and clinical practice through its comprehensive coverage of topics ranging from liver diseases to gastrointestinal disorders. With an impressive Q2 ranking in Gastroenterology and a Q3 ranking in Hepatology as of 2023, the journal has established itself as an influential platform for researchers and healthcare professionals seeking to disseminate and acquire knowledge. The journal is based in Egypt, with its operational headquarters located in London, England. Notably, it holds a respectable standing in Scopus rankings, placed at Rank #64 in Gastroenterology and Rank #34 in Hepatology, reflecting its impact and relevance in the medical community. With a commitment to quality and accessibility, the Canadian Journal of Gastroenterology and Hepatology continues to foster innovation and collaboration among its readers.